Invivyd, Inc.
IVVD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001832038
In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Invivyd, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 80 | 2 | 76 | −2 |
| Shares | 76.0M | 4.58M | 71.5M | +84.5K (+0.1%) |
| Value | $83.5M | $5.04M | $72.9M | −$5.60M (−7.1%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Invivyd, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,671,723 | $4.77M | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 44,305 | $45.2K | 0.00% |
| Proficio Capital Partners LLC | 26,706 | $27.2K | 0.00% |
| Sandia Investment Management LP | 26,706 | $27.2K | 0.04% |
| AQR Capital Management LLC | 20,300 | $20.7K | 0.00% |
| ProShare Advisors LLC | 14,984 | $15.3K | 0.00% |
| Voya Investment Management LLC | 11,054 | $11.3K | 0.00% |
| HSBC Holdings PLC | 10,053 | $10.4K | 0.00% |
| CWM, LLC | 631 | $1.00K | 0.00% |
| Claris Advisors, LLC | 500 | $510 | 0.00% |
| Parallel Advisors, LLC | 496 | $506 | 0.00% |
| Nisa Investment Advisors, LLC | 256 | $261 | 0.00% |
| Sterling Capital Management LLC | 252 | $257 | 0.00% |
| Allspring Global Investments Holdings, LLC | 157 | $160 | 0.00% |
| Capital Performance Advisors LLP | 85 | $87 | 0.00% |
Sold out (17)
Institutions that held Invivyd, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Renaissance Technologies LLC | 382,818 | $421.1K |
| Man Group plc | 196,598 | $216.3K |
| Dimension Capital Management LLC | 189,871 | $208.9K |
| Wellington Management Group LLP | 187,788 | $206.6K |
| Cubist Systematic Strategies, LLC | 134,452 | $147.9K |
| Alpine Global Management, LLC | 83,376 | $91.7K |
| Cornercap Investment Counsel Inc | 77,753 | $85.5K |
| Squarepoint Ops LLC | 74,565 | $82.0K |
| XTX Topco Ltd | 37,938 | $41.7K |
| Marathon Trading Investment Management LLC | 36,570 | $40.2K |
| Point72 Asia (Singapore) Pte. Ltd. | 35,022 | $38.5K |
| Toroso Investments, LLC | 26,457 | $29.1K |
| Gsa Capital Partners LLP | 24,744 | $27.0K |
| Gilder Gagnon Howe & Co LLC | 17,971 | $19.8K |
| Oxford Asset Management LLP | 15,570 | $17.1K |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 2,000 | $2.78K |
| Federated Hermes, Inc. | 1,108 | $1.22K |
Not filed for Q3 2024 yet (2)
Institutions that held Invivyd, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 4,473,808 | $4.92M |
| Susquehanna Fundamental Investments, LLC | 104,732 | $115.2K |